marijuana stock news

Form 8-K for NUVILEX, INC.

9-Jan-2015

Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Regulation FD Disc

Item 5.03 Amendments to Articles of Incorporation or BylawsEffective January 6, 2015, Nuvilex, Inc. (“Company”) changed its legal corporate name to “PharmaCyte Biotech, Inc.” The name change was effected through a short-form merger pursuant to Section 92A.180 of the Nevada Revised Statutes. A wholly-owned subsidiary of the Company was merged with and into the Company, with the Company as the surviving entity of the merger. The merger had the effect of amending the Company’s Certificate of Incorporation to reflect the new legal name of the Company. A copy of the Articles of Merger effecting the name change, as filed with the Secretary of State of the State of Nevada, is attached hereto as Exhibit 3.1. The Articles of Merger became effective by their terms on January 6, 2015.

In connection with the name change, the Company also changed the ticker symbol of its common stock, which previously traded under the ticker symbol “NVLX.” The Company’s common stock is trading under the ticker symbol “PMCB.”

The merger and resulting name change do not affect the rights of the Company’s security holders, creditors, customers or suppliers. With the exception of the name change, there were no changes to the Company’s Certificate of Incorporation or Bylaws.

Item 7.01. Regulation FD DisclosureOn January 7, 2015, the Company issued a press release announcing the name change, a copy of which is attached hereto as Exhibit 99.1. On January 8, 2015, the Company issued a press release announcing the new ticker symbol, a copy of which is attached hereto as Exhibit 99.2. The information furnished in this Item 7.01, including Exhibits 99.1 and 99.2, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section.

Item 9.01 Financial Statements and Exhibits.(d) Exhibits.

3.1 Articles of Merger merging PharmaCyte Biotech, Inc. with and into Nuvilex, Inc., effective January 6, 2015
99.1 Press Release dated January 7, 2015
99.2 Press Release dated January 8, 2015


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
1 comment
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

GrowGeneration Corp. (GRWG) Announces Opening of the Largest Hydroponic Garden Centers in Los Angeles County

GrowGeneration Announces Opening of the Largest Hydroponic Garden Centers in Los Angeles…

GT Biopharma Announces Update To OXS-3550 IND Filing, Its Most Advanced Tri-Specific Killer Engager

LOS ANGELES, CA, May 16, 2018 – GT Biopharma Inc. (OTCQB: GTBP…

Village Farms International, Inc. (VFF) to Report Q2/24 Results on August 8, 2024

Village Farms International to Report Q2/24 Results on August 8, 2024 Village…

4Front Ventures Corp. (FFNTF) to Report Third Quarter 2023 Financial Results on November 14, 2023

4Front Ventures to Report Third Quarter 2023 Financial Results on November 14,…